Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, Finland.
Schizophr Res. 2010 Oct;123(1):77-85. doi: 10.1016/j.schres.2010.07.025. Epub 2010 Aug 21.
The current criteria for detecting a Clinical High-Risk (CHR) state for psychosis do not address cognitive impairment. A first step for identifying cognitive markers of psychosis risk would be to determine which aspects of neurocognitive performance are related with more severe psychotic-like symptoms. This study assessed cognitive impairment associated with prodromal symptoms in adolescents receiving public psychiatric treatment.
189 adolescents were recruited from consecutive new patients aged 15-18 attending mainly outpatient adolescent psychiatric units in Helsinki. They had been screened for prodromal symptoms using the Prodromal Questionnaire, and all screen-positives as well as a random sample of screen-negatives were interviewed using the Structured Interview for Prodromal Symptoms (SIPS) and underwent testing using a large, standardized neurocognitive test battery. The sample included 62 adolescents who met the CHR criteria (CHR) and 112 who did not (non-CHR). A healthy control sample (n=72) was also included to provide age- and gender-matched norms.
The CHR group performed worse on visuospatial tasks than the non-CHR group. Among CHR adolescents, negative symptoms were associated with slower processing speed and poorer performance on verbal tasks. Among non-CHR adolescents, positive symptoms were associated with poorer performance on visuospatial tasks, and negative symptoms with poorer performance on verbal tasks.
Clinical high-risk status is associated with impaired visuospatial task performance. However, both positive, psychotic-like symptoms and negative symptoms are associated with lower levels of neurocognitive functioning among adolescents in psychiatric treatment regardless of whether CHR criteria are met. Thus, even mild positive and negative symptoms may have clinical relevance in adolescents in psychiatric care. Adolescents with both psychotic-like symptoms and neurocognitive deficits constitute a group requiring special attention.
目前用于检测精神病临床高风险(CHR)状态的标准并未涉及认知障碍。确定精神病风险认知标志物的第一步是确定神经认知表现的哪些方面与更严重的类精神病症状相关。本研究评估了接受公共精神科治疗的青少年前驱症状相关的认知障碍。
从主要在赫尔辛基门诊青少年精神科就诊的 15-18 岁连续新患者中招募了 189 名青少年。他们使用前驱症状问卷(Prodromal Questionnaire)进行了前驱症状筛查,所有筛查阳性者以及随机选择的筛查阴性者均使用前驱症状结构化访谈(Structured Interview for Prodromal Symptoms,SIPS)进行访谈,并使用大型标准化神经认知测试组合进行测试。该样本包括符合 CHR 标准(CHR)的 62 名青少年和不符合 CHR 标准(非-CHR)的 112 名青少年。还纳入了一个健康对照组(n=72),以提供年龄和性别匹配的常模。
CHR 组在视空间任务上的表现不如非 CHR 组。在 CHR 青少年中,阴性症状与较慢的加工速度和言语任务表现较差相关。在非 CHR 青少年中,阳性症状与视空间任务表现较差相关,阴性症状与言语任务表现较差相关。
临床高风险状态与视空间任务表现受损相关。然而,无论是符合 CHR 标准与否,阳性、类精神病症状和阴性症状都与精神科治疗中的青少年的神经认知功能水平较低相关。因此,即使是轻度的阳性和阴性症状在精神科护理中的青少年中也可能具有临床意义。既有类精神病症状又有神经认知缺陷的青少年构成了一个需要特别关注的群体。